Nanjing Pharmaceutical Co., Ltd. (600713)
Market Closed
11 Aug, 06:57
SSE SSE Primary ¥
5. 27
+0.07
+1.3462%
¥
6.34B Market Cap
- P/E Ratio
0.64% Div Yield
20.4M Volume
- Eps
¥ 5.2
Previous Close Want to track 600713 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | 0.05 |
| | | - | 0.04 |
| | | - | 0.06 |
| | | - | 0.05 |
| | | - | 0.04 |
| | | - | 0.05 |
| | | - | 0.04 |
| | | - | 0.02 |
600713 Earnings Reports FAQ
What is the earnings per share (EPS) for 600713?
EPS data for 600713 is currently not available, as Nanjing Pharmaceutical Co., Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 10 years, the earnings growth rate has been approximately 53.87%, reflecting the 600713's performance and SSE market conditions.
When is the next earnings release date?
Nanjing Pharmaceutical Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Nanjing Pharmaceutical Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 600713 at this time, as Nanjing Pharmaceutical Co., Ltd has no recent EPS data to calculate it.
